Abstract:Beta-blockers have been considered as an effective treatment in secondary prevention of coronary heart disease (CHD). However, there is still disputed whether beta-blockers can increase all-cause mortality in patients with coronary heart disease and diabetes mellitus (DM). Here, our systematic review and meta-analysis is aiming to assess the effects of beta-blockers on all-cause mortality in patients with coronary heart disease and diabetes mellitus. Four databases (PubMed, Embase, Cochrane Library and Web of Science) and other sources were searched to collect randomized controlled trials (RCTs) and cohort studies related to the treatment of beta-blockers for coronary heart disease and diabetes mellitus patients. We further evaluated quality of evidence using the grading of recommendations assessment, development, and evaluation (GRADE) approach. Finally, a total of 16,188 records were identified, and four randomized controlled trials and six cohort studies (206,490 patients) were included. Random effects analysis revealed that beta-blockers combined with routine treatment (RT) significantly decreased all-cause mortality in patients with coronary heart disease and diabetes mellitus compared with RT in control group (RR 0.59, 95% CI 0.47 to 0.75; p < 0.000 01; I-2 = 72%). Subgroup analysis of all-cause mortality by the subtype of diabetes mellitus and definite MI patients (RR 0.54, 95% CI 0.45 to 0.65, p < 0.000 01, I-2 = 29%) and the subtype of randomized controlled trials (RR 0.49, 95% CI 0.32 to 0.76, p = 0.001, I-2 = 0%) indicated a relatively small heterogeneity and stable results. beta-blockers application significantly reduced cardiovascular death as well (RR 0.56, 95% CI 0.42 to 0.74; p < 0.000 1; I-2 = 0%). Our meta-analysis provided critical evidence of beta-blockers treatment for patients with coronary heart disease (especially MI type) and diabetes mellitus, and discussed the advantages and potential metabolic risks for the clinical use of beta-blockers. This study suggested that beta-blockers application may improve all-cause mortality and cardiovascular death in coronary heart disease (especially MI type) and diabetes mellitus patients. However, given a small number of included studies, the aforementioned conclusion should be confirmed in a multi-center, large-scale, and strictly designed trial.

433 IMPACT OF HEART RATE ON CENTRAL HEMODYNAMICS AND STROKE

Impact of Heart Rate on Central Hemodynamics and Stroke: a Meta-Analysis of Β-Blocker Trials.

Resting heart rate control and prognosis in coronary artery disease patients with hypertension previously treated with bisoprolol: a sub-group analysis of the BISO-CAD study.

Heart Rate Control is Associated with Reduced Cardiovascular Events in Asian Patients with Coronary Artery Disease Treated with Bisoprolol (BISO-CAD): Results from a Multi-National, Real-World Experience

Antihypertensive Treatment and Central Arterial Hemodynamics: A Meta-Analysis of Randomized Controlled Trials

HEART RATE REDUCTION WITH BETA-BLOCKERS REDUCED LEFT ATRIAL FUNCTION IN HYPERTENSIVE PATIENTS WITH RECURRENT ATRIAL FIBRILLATION

A randomized controlled study on the effects of bisoprolol and atenolol on sympathetic nervous activity and central aortic pressure in patients with essential hypertension.

Role Of Blood Pressure Management In Stroke Prevention: A Systematic Review And Network Meta-Analysis Of 93 Randomized Controlled Trials

Long-term Beta Blockers for Stable Angina: Systematic Review and Meta-Analysis

Effect of exercise based on ACSM recommendations on blood pressure and heart rate in hypertensive patients: A systematic review and meta-analysis of randomized controlled trials

Beta-blocker efficacy across different cardiovascular indications: an umbrella review and meta-analytic assessment

Effects of -blockers on all-cause mortality in patients with diabetes and coronary heart disease: A systematic review and meta-analysis

Incident stroke events in clinical trials of antihypertensive drugs in cardiovascular disease patients: A network meta-analysis of randomized controlled trials

Cardiovascular Risk and Blood Pressure Reduction: an Overview of the Outcome Trials

Beta-blockers in hypertension: overview and meta-analysis of randomized outcome trials.

The effect of metoprolol on heart rate variability in patients with hypertension

Effect Of Metoprolol Succinate In Patients With Stable Angina And Elevated Heart Rate Receiving Low-Dose Beta-Blocker Therapy

Effects of Β-Blockers on All-Cause Mortality in Patients with Diabetes and Coronary Heart Disease: A Systematic Review and Meta-Analysis

Prognostic Significance of Heart Rate and Beta-Blocker Use in Sinus Rhythm in Patients with Heart Failure and Preserved Ejection Fraction

Efficacy of Ivabradine Versus Β-Blockers for Heart Rate Reduction During Computed Tomography Coronary Angiography: A Meta-Analysis of Randomized Controlled Trials.

Meta-Analysis of Relation Between Oral β-Blocker Therapy and Outcomes in Patients With Acute Myocardial Infarction Who Underwent Percutaneous Coronary Intervention.